Karyopharm Therapeutics Inc (KPTI) gets rating Initiated from Piper Sandler
Karyopharm Therapeutics Inc’s filing revealed that its President and CEO Paulson Richard A. unloaded Company’s shares for reported $4645.0 on Mar 05 ’24. In the deal valued at $1.30 per share,3,573 shares were sold. As a result of this transaction, Paulson Richard A. now holds 1,160,836 shares worth roughly $1.61 million. Then, Paulson Richard A. […]
KPTI short interest surges, indicating growing pessimism among investors
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Karyopharm Therapeutics Inc shares valued at $4,645 were sold by Paulson Richard A. on Mar 05 ’24. At $1.30 per share, Paulson Richard A. sold 3,573 shares. The insider’s holdings dropped to 1,160,836 shares worth approximately $1.65 […]
Karyopharm Therapeutics Inc [KPTI] Insider Paulson Richard A. sells 3,573 Shares – Insider Selling Alert
Karyopharm Therapeutics Inc’s recently made public that its President and CEO Paulson Richard A. unloaded Company’s shares for reported $4645.0 on Mar 05 ’24. In the deal valued at $1.30 per share,3,573 shares were sold. As a result of this transaction, Paulson Richard A. now holds 1,160,836 shares worth roughly $1.71 million. Then, Paulson Richard […]
Insider Selling: Paulson Richard A., Karyopharm Therapeutics Inc [KPTI] President and CEO divested 3,573 shares
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Karyopharm Therapeutics Inc shares valued at $4,645 were sold by Paulson Richard A. on Mar 05 ’24. At $1.30 per share, Paulson Richard A. sold 3,573 shares. The insider’s holdings dropped to 1,160,836 shares worth approximately $1.56 […]
KPTI (Karyopharm Therapeutics Inc) may reap gains as insiders became active recently
Karyopharm Therapeutics Inc’s filing revealed that its President and CEO Paulson Richard A. unloaded Company’s shares for reported $4645.0 on Mar 05 ’24. In the deal valued at $1.30 per share,3,573 shares were sold. As a result of this transaction, Paulson Richard A. now holds 1,160,836 shares worth roughly $1.72 million. Then, Paulson Richard A. […]
A company insider recently sold 3,573 shares of Karyopharm Therapeutics Inc [KPTI]. Should You Sale?
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Karyopharm Therapeutics Inc shares valued at $4,645 were sold by Paulson Richard A. on Mar 05 ’24. At $1.30 per share, Paulson Richard A. sold 3,573 shares. The insider’s holdings dropped to 1,160,836 shares worth approximately $1.78 […]
Taking a Closer Look At Karyopharm Therapeutics Inc (KPTI) Following Its Recent Trade
In a filing, Karyopharm Therapeutics Inc revealed its President and CEO Paulson Richard A. unloaded Company’s shares for reported $23249.0 on Mar 01. In the deal valued at $1.20 per share,19,374 shares were sold. As a result of this transaction, Paulson Richard A. now holds 1,164,409 shares worth roughly $1.53 million. Then, Mason Michael sold […]
A company insider recently sold 5,847 shares of Karyopharm Therapeutics Inc [KPTI]. Should You also Consider to Sale?
Karyopharm Therapeutics Inc’s recent filing unveils that its EVP, Chief Development Officer Poulton Stuart unloaded Company’s shares for reported $7783.0 on Feb 15. In the deal valued at $1.33 per share,5,847 shares were sold. As a result of this transaction, Poulton Stuart now holds 163,772 shares worth roughly $0.23 million. Then, Mason Michael sold 4,205 […]
A company insider recently sold 5,847 shares of Karyopharm Therapeutics Inc [KPTI]. Should You Sale?
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Karyopharm Therapeutics Inc shares valued at $7,783 were sold by Poulton Stuart on Feb 15. At $1.33 per share, Poulton Stuart sold 5,847 shares. The insider’s holdings dropped to 163,772 shares worth approximately $0.2 million following the […]
Karyopharm Therapeutics Inc [KPTI] Shares Fall Approximately -59.04% Over the Year
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Karyopharm Therapeutics Inc shares valued at $6,671 were sold by Mason Michael on Feb 06. At $1.59 per share, Mason Michael sold 4,205 shares. The insider’s holdings dropped to 246,945 shares worth approximately $0.34 million following the […]